Myeloma Proteins and the Clinical Response to Melphalan Therapy

D. E. Bergsagel, P. J. Migliore, K. M. Griffith
1965 Science  
Objective improvement after therapy with melphalan occurred in all patients producing only Bence Jones kappa proteins, in half of the patients with myeloma serum proteins, and in none of those producing only Bence Jones lambda proteins.
doi:10.1126/science.148.3668.376 pmid:14261530 fatcat:fwzrswohzbbblnqkvuplzoix7a